Answers are grounded in this paper and cite their sources.
Nitazoxanide is a new compound with broad-spectrum activity against numerous intestinal protozoa, helminths and anaerobic bacteria. It is approved for the treatment of diseases caused by Giardia intestinalis and Cryptosporidium species. The drug is well tolerated, with few side effects and requires a short course of treatment. Further investigations regarding its use in patients with AIDS is needed. Nitazoxanide represents a significant advance in the treatment of intestinal parasitic infections worldwide.
No takes yet. Share an insight, caveat, or question.
Aslam et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: